Alkemy Capital. Share News (ALK)

Alkane Energy: Liberum Capital initiates with a target price of 44p and a buy recommendation.Anite: Panmure Gordon shifts target price from 170p to 171p and maintains a buy recommendation.Atkins: Credit Suisse raises target price from 770p to 822p, but downgrades to underperform.Avacta Group: Numis initiates with a target price of 1.70p and a buy recommendation.Betfair: Jefferies increases target price from 850p to 930p retaining a buy recommendation.BG Group: Deutsche Bank moves target price from 1350p to 1400p and upgrades to buy.British Polythene Industries: Investec moves target price from 575p to 600p and stays with its buy recommendation.Cineworld: Investec takes target price from 310p to 347p retaining its buy recommendation.Cobham: Jefferies ups target price from 240p to 290p and maintains its buy recommendation.CRH: Deutsche Bank reduces target price from 1600p to 1520p, while keeping a buy recommendation.CSR: JP Morgan raises target price from 475p to 530p reiterating an overweight rating. Deutsche Bank ups target price from 300p to 325p, but still recommends selling. Canaccord Genuity increases target price from 475p to 540p, while downgrading from buy to hold.Dixons Retail: Nomura shifts target price from 23'p to 31p and keeps a neutral rating.Euromoney: Investec increases target price from 990p to 1080p staying with its buy recommendation.Gable Holdings: Panmure Gordon shifts target price from 63p to 71p and stays with its buy recommendation.Genel Energy: JP Morgan takes target price from 967p to 1100p leaving its neutral rating unchanged.G4F: Espirito Santo cuts target price from 250p to 215p and stays with its sell recommendation.Hammerson: Investec revises target price from 490p to 525p and retains a reduce rating.HSBC Holdings: JP Morgan ups target price from 755p to 800p and retains an overweight rating. Exane BNP lowers target price from 825p to 800p and keeps an outperform rating.IMI: Investec reduces target price from 1355p to 1295p keeping a hold recommendation.InterContinental Hotels Group: Credit Suisse reduces target price from 1906p to 1850p, while its neutral rating remains unaltered.Intu Properties: Exane BNP shifts target price from 340p to 330p reiterating a neutral rating. Credit Suisse reduces target price from 350p to 325p and downgrades from neutral to underperform.Morgan Sindall: Liberum Capital cuts target price from 535p to 500p maintaining its hold recommendation.Morrison (Wm): Bank of America increases target price from 284p to 304p, while downgrading to neutral. Panmure Gordon ups target price from 240p to 260p, but still recommends selling.Next: Deutsche Bank 4600p to 4850p and maintains its buy recommendation.Northgate: Panmure Gordon increases target price from 230p to 298p, but still recommends selling.Restaurant Group: Numis downgrades to reduce with a target price of 400p.Sage Group: Credit Suisse ups target price from 284p to 301p retaining an underperform rating. Canaccord Genuity raises target price from 327p to 350p and keeps a hold recommendation.Sainsbury: Nomura takes target price from 355p to 380p, while its neutral rating remains unchanged.Songbird Estates: Investec raises target price from 100p to 1550p retaining a hold recommendation.Spirax-Sarco Engineering: Investec cuts target price from 2745p to 2600p keeping a hold rating.Standard Chartered: Morgan Stanley reduces target price from 2020p to 1830p, while reiterating an overweight rating. Nomura cuts target price from 1950p to 1880p leaving its buy recommendation unchanged. JP Morgan moves target price from 2000p to 1920p and downgrades to neutral (from overweight). Exane BNP revises target price from 1750p to 1600p and keeps a neutral rating. Numis reduces target price from 2057p to 1708p downgrading to hold.Supergroup: Panmure Gordon ups target price from 788p to 836p and keeps a buy recommendation. Canaccord Genuity increases target price from 850p to 1000p maintaining a buy recommendation.United Drug: Jeffferies moves target price from 310p to 340p and leaves its buy recommendation unaltered. Investec places its target price (prev.: 240p) under review, while maintaining its sell recommendation.3i Group: Morgan Stanley raises target price from 291p to 351p keeping an equal-weight rating.